Cargando…

Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma

To examine the effect of non‐steroidal anti‐inflammatory drugs on metastasis formation, aspirin (ASP, 0.5% in diet) and indomethacin (IM, 0.005% in drinking water) were applied to an in vivo highly metastatic rat hepatocellular carcinoma (HCC) model in F344 male rats. Administration for 8 weeks afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Futakuchi, Mitsuru, Ogawa, Kumiko, Sano, Masashi, Tamano, Seiko, Takeshita, Fumitaka, Shirai, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926880/
https://www.ncbi.nlm.nih.gov/pubmed/12417048
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01220.x
_version_ 1783318989216153600
author Futakuchi, Mitsuru
Ogawa, Kumiko
Sano, Masashi
Tamano, Seiko
Takeshita, Fumitaka
Shirai, Tomoyuki
author_facet Futakuchi, Mitsuru
Ogawa, Kumiko
Sano, Masashi
Tamano, Seiko
Takeshita, Fumitaka
Shirai, Tomoyuki
author_sort Futakuchi, Mitsuru
collection PubMed
description To examine the effect of non‐steroidal anti‐inflammatory drugs on metastasis formation, aspirin (ASP, 0.5% in diet) and indomethacin (IM, 0.005% in drinking water) were applied to an in vivo highly metastatic rat hepatocellular carcinoma (HCC) model in F344 male rats. Administration for 8 weeks after induction of highly metastatic HCC by sequential treatment with diethylnitrosamine and N‐nitrosomorpholine did not cause any significant change in survival rate or body weight. Multiplicity of HCC in the liver increased during ASP or IM treatment without any significant histological alteration. Although absent in the rats killed at the end of the period of carcinogen exposure, lung metastasis at the end of the experiment was found in 100%, 89% and 100% of rats in the control, ASP and IM groups, respectively. Degree of metastasis was classified into three groups according to the number of metastatic nodules, i.e., slight (1–5 nodules), moderate (6–50) and severe (more than 51), which amounted to 0%, 43% and 57% in the control group. ASP significantly reduced the degree of metastasis, the incidences being 33%, 44%, and 11%, respectively, whereas IM was without significant influence. Both agents suppressed cell proliferation in HCCs, without any alteration of pan‐cadherin expression. However, expression in HCC of mRNAs for intercellular adhesion molecule‐1 and vascular cell adhesion molecule‐1, both of which are considered to play key roles in attachment of cancer cells to the endothelium, was significantly suppressed by ASP. Thus, the present study demonstrated that ASP, but not IM, has the potential to inhibit lung metastasis of rat HCC in vivo, possibly via reduced attachment of tumor cells to the vascular endothelium. Moreover, these data indicate this in vivo model for induction of rat highly metastatic HCC to be a useful tool for the assessment of the efficacy of therapeutic treatments to block metastasis formation.
format Online
Article
Text
id pubmed-5926880
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59268802018-05-11 Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma Futakuchi, Mitsuru Ogawa, Kumiko Sano, Masashi Tamano, Seiko Takeshita, Fumitaka Shirai, Tomoyuki Jpn J Cancer Res Article To examine the effect of non‐steroidal anti‐inflammatory drugs on metastasis formation, aspirin (ASP, 0.5% in diet) and indomethacin (IM, 0.005% in drinking water) were applied to an in vivo highly metastatic rat hepatocellular carcinoma (HCC) model in F344 male rats. Administration for 8 weeks after induction of highly metastatic HCC by sequential treatment with diethylnitrosamine and N‐nitrosomorpholine did not cause any significant change in survival rate or body weight. Multiplicity of HCC in the liver increased during ASP or IM treatment without any significant histological alteration. Although absent in the rats killed at the end of the period of carcinogen exposure, lung metastasis at the end of the experiment was found in 100%, 89% and 100% of rats in the control, ASP and IM groups, respectively. Degree of metastasis was classified into three groups according to the number of metastatic nodules, i.e., slight (1–5 nodules), moderate (6–50) and severe (more than 51), which amounted to 0%, 43% and 57% in the control group. ASP significantly reduced the degree of metastasis, the incidences being 33%, 44%, and 11%, respectively, whereas IM was without significant influence. Both agents suppressed cell proliferation in HCCs, without any alteration of pan‐cadherin expression. However, expression in HCC of mRNAs for intercellular adhesion molecule‐1 and vascular cell adhesion molecule‐1, both of which are considered to play key roles in attachment of cancer cells to the endothelium, was significantly suppressed by ASP. Thus, the present study demonstrated that ASP, but not IM, has the potential to inhibit lung metastasis of rat HCC in vivo, possibly via reduced attachment of tumor cells to the vascular endothelium. Moreover, these data indicate this in vivo model for induction of rat highly metastatic HCC to be a useful tool for the assessment of the efficacy of therapeutic treatments to block metastasis formation. Blackwell Publishing Ltd 2002-10 /pmc/articles/PMC5926880/ /pubmed/12417048 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01220.x Text en
spellingShingle Article
Futakuchi, Mitsuru
Ogawa, Kumiko
Sano, Masashi
Tamano, Seiko
Takeshita, Fumitaka
Shirai, Tomoyuki
Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title_full Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title_fullStr Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title_full_unstemmed Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title_short Suppression of Lung Metastasis by Aspirin but Not Indomethacin in an in vivo Model of Chemically Induced Hepatocellular Carcinoma
title_sort suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926880/
https://www.ncbi.nlm.nih.gov/pubmed/12417048
http://dx.doi.org/10.1111/j.1349-7006.2002.tb01220.x
work_keys_str_mv AT futakuchimitsuru suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma
AT ogawakumiko suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma
AT sanomasashi suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma
AT tamanoseiko suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma
AT takeshitafumitaka suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma
AT shiraitomoyuki suppressionoflungmetastasisbyaspirinbutnotindomethacininaninvivomodelofchemicallyinducedhepatocellularcarcinoma